SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Fitterling James R

(Last) (First) (Middle)
2030 DOW CENTER

(Street)
MIDLAND MI 48674

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/14/2010
3. Issuer Name and Ticker or Trading Symbol
DOW CHEMICAL CO /DE/ [ DOW ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior Vice President
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common 92,483.0196(1) D
Common 740.07 I By 401(k) Plan
Common 1,540.7 I By 401(k) Plan ESOP
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy)(2) (3) 02/13/2019 Common 76,720 $9.53 D
Non-Qualified Stock Option (right to buy)(2) (4) 02/14/2013 Common 12,500 $27.4 D
Non-Qualified Stock Option (right to buy)(2) (5) 02/12/2020 Common 115,700 $27.79 D
Non-Qualified Stock Option (right to buy)(2) (6) 02/15/2012 Common 6,700 $30.425 D
Non-Qualified Stock Option (right to buy)(2) (7) 02/18/2018 Common 70,960 $38.62 D
Non-Qualified Stock Option (right to buy)(2) (8) 02/13/2014 Common 11,170 $43.49 D
Non-Qualified Stock Option (right to buy)(2) (9) 02/16/2017 Common 39,050 $43.59 D
Non-Qualified Stock Option (right to buy)(2) (10) 03/01/2016 Common 18,610 $43.675 D
Non-Qualified Stock Option (right to buy)(2) (11) 02/18/2015 Common 13,000 $53.525 D
Phantom Stock Units (12) (12) Common 393.38 (12) D
Explanation of Responses:
1. Total includes deferred stock amounts to be delivered in one installment on or about the following dates contingent upon employment: 8,170 shares on February 15, 2011; 2,270 shares on March 1, 2011; 11,720 shares on February 13, 2012; 5,010 shares on February 16, 2012 and 19,100 shares on February 12, 2013. Granted under The Dow Chemical Company 1988 Award and Option Plan. The Plan provides for tax withholding rights.
2. Granted under The Dow Chemical Company 1988 Award and Option Plan. The Plan provides for tax withholding rights.
3. The options vest in three equal annual installments beginning on February 13, 2010.
4. The options vest in three equal annual installments beginning on February 14, 2004.
5. The options vest in three equal annual installments beginning on February 12, 2011.
6. The options vest in three equal annual installments beginning on February 15, 2003.
7. The options vest in three equal annual installments beginning on February 15, 2009.
8. The options vest in three equal annual installments beginning on February 13, 2005.
9. The options vest in three equal annual installments beginning on February 16, 2008.
10. The options vest in three equal annual installments beginning on March 1, 2007.
11. The options vest in three equal annual installments beginning on February 18, 2006.
12. These securities generally do not carry a conversion price, exercisable date or expiration date.
Remarks:
/s/ James R Fitterling 04/22/2010
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.